Submitted:
12 December 2025
Posted:
18 December 2025
You are already at the latest version
Abstract
In this study, three point mutations of EGFR relevant to lung cancer therapy are detected. Mutated EGFR is the target of a therapy for non-small cell lung cancer (NSCLC) using tyrosine kinase inhibitors (TKIs) as treatment drugs. Background/Objectives: Point mutations in exon 21 (L858R and L861Q) of the EGFR gene are TKI-sensitive; however, mutations in exon 20 (T790M) are TKI-resistant. Therefore, a fast detection method that classifies a NSCLC patient to be drug sensitive or drug resistant is highly clinically relevant. Methods: Probes were designed to detect three point mutations in genomic samples based on DNA hybridization on a solid surface. A method has been developed to detect single nucleotide polymorphism (SNP) for these mutation detections in the 16-channel nanobioarray chip. The wash by gold-nanoparticles (AuNP) was used to assist the differentiation detection Results: The gold nanoparticle-assisted wash method has enhanced differentiation between WT and mutated sequences relevant to the EGFR sensitivity to tyrosine kinase inhibitors. Conclusions: The WT and mutated sequences (T790M, L858R and L861Q) in genomic samples were successfully differentiated from each other.
Keywords:
1. Introduction
2. Materials and Methods
2.1. Microfluidic Device Fabrication
2.2. DNA Sequences, Probes, Primers and 60-Mer Oligonucleotide Design
2.3. Genomic DNA and Polymerase Chain Reaction (PCR)
2.4. Probe Immobilization, Target Hybridization and Fluorescent Detection
3. Results and Discussion
3.1. Differentiation of ssDNA Samples
3.2. Differentiation of PCR Strands
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Herbst, R. “Review of Epidermal Growth Factor Receptor Biology”. Int. J. Radiation Oncology Biol. Phys. 2004, 59(2), 21–26. [Google Scholar] [CrossRef] [PubMed]
- Zhang, H.; Berezov, A.; Wang, Q.; Zhang, G.; Drebin, J.; Murali, R.; Greene, M.I. ErbB receptors: from oncogenes to targeted cancer therapies. Journal of Clinical Investigation 2007, 117(8), 2051–2058. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.W.; Weng, X.H.; Wang, C.L.; Lin, W.W.; Liu, A.L.; Chen, W.; Lin, X.H. “Detection EGFR exon 19 status of lung cancer patients by DNA electrochemical biosensor”. Biosensors and Bioelectronics 2016, 80, 411–417. [Google Scholar] [CrossRef] [PubMed]
- Cerami, E.; Sawyers, C.L. “AACR Project GENIE: Powering Precision Medicine through an International Consortium”. Cancer Discovery 2017, 7, 818–31. [Google Scholar] [CrossRef] [PubMed]
- Yasuda, H.; Kobayashi, S.; Costa, D.B. EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. Lancet Oncology 2012, 13, e23–e31. [Google Scholar] [CrossRef] [PubMed]
- Yamamoto, H.; Toyooka, S.; Mitsudomi, T. Impact of EGFR mutation analysis in non-small cell lung cancer. Lung Cancer 2009, 63, 315–21. [Google Scholar] [CrossRef] [PubMed]
- Oberc, Christopher; Li, Paul C.H. Next-Generation DNA Sequencing of Panax Samples Revealed New Genotypes: Burrows-Wheeler Aligner, Python and Clustering Analysis. Heliyon 2024, 10(e29104), 1–10. [Google Scholar] [CrossRef] [PubMed]
- Jing, C; Mao, X; Wang, Z; Sun, K; Ma, R; Wu, J; Cao, H. Next-generation sequencing-based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her-2 and TP53 mutations in patients with non-small cell lung cancer. Mol Med Rep. 2018, 18, 2191–2197. [Google Scholar] [CrossRef] [PubMed]
- Wang, Lin; Li, Paul C.H. “Microfluidic DNA Microarray Analysis: A Review”. Anal. Chim. Acta, invited review 2011, 687, 12–27. [Google Scholar] [CrossRef] [PubMed]
- Xuyang, Pu; Xueqiang, Wu. Advances in nucleic acid probe-based detection of gene point mutations: a review. Frontiers in Chemistry 2025, 13, 1672155. [Google Scholar] [CrossRef] [PubMed]
- Wang, L. Flexible microarray construction and fast DNA hybridization conducted on a microfluidic chip for greenhouse plant fungal pathogen detection. J. Agric. Food Chem 2007, 55, 10509–16. [Google Scholar] [CrossRef] [PubMed]
- Wang, Lin; Li, Paul C.H. “Optimization of a microfluidic microarray device for the fast discrimination of fungal pathogenic DNA”. Anal. Biochem. 400(2010), 282–288. [CrossRef] [PubMed]
- Sedighi, Abootaleb; Li, Paul C.H. Kras Gene codon 12 mutation detection enabled by Gold Nanoparticles conducted in a NanoBioArray chip. Anal. Biochem. 448, 58–64. [CrossRef] [PubMed]
- Wang, Lin; Li, Paul C.H. “Gold nanoparticle-assisted single base-pair mismatch discrimination on a microfluidic microarray device”. Biomicrofluidics 2010, 4, 032209. [Google Scholar] [CrossRef] [PubMed]
- Sedighi, A. A proposed mechanism of the influence of gold nanoparticles on DNA hybridization. ACS Nano 2014, 8(7), 6765–6777. [Google Scholar] [CrossRef] [PubMed]
- Sedighi, Abootaleb; Whitehall, Vicki; Li, Paul C.H. “Enhanced destabilization of mismatched DNA using gold nanoparticles offers specificity without compromising sensitivity for nucleic acid analyses”. Nano Research 2015, 8, 3922–3933. [Google Scholar] [CrossRef]







| Acronym | Description | Length | Sequences (5’–3’) with labels |
|---|---|---|---|
| E20_WT | Exon 20 WT probe | 22 | NH2-(CH2)12-CAT GAG CTG CGT GAT GAG CTG C |
| T790M | Exon 20 Mut probe | 22 | NH2-(CH2)12-CAT GAG CTG CAT GAT GAG CTG C |
| E21_WT | Exon 21 WT probe | 21 | NH2-(CH2)12-AGC AGT TTG GCC AGC CCA AAA |
| L858R | Exon 21 Mut site (1) | 20 | NH2-(CH2)12-TTG GCC CGC CCA AAA TCT GT |
| L861Q | Exon 21 Mut site (2) | 21 | NH2-(CH2)12-TCT TCC GCA CCC AGC TGT TTG |
| E20_F_Bio | Exon 20 Forward primer, biotin labeled | 19 | Bio-AAG CCT ACG TGA TGG CCA G |
| E20_R | Exon 20 Reverse primer | 22 | CTT TGC GAT CTG CAC ACA CCA G |
| E21_F_Bio | Exon 21 Forward primer, biotin labeled | 22 | Bio-GGG CAT GAA CTA CTT GGA GGA C |
| E21_R | Exon 21 Reverse primer | 22 | TTT GCC TCC TTC TGC ATG GTA T |
| E20W60 | Exon 20, 60-mer oligonucleotides represents WT sequences, biotin labeled | 60 | Bio-CCT CAC CTC CAC CGT GCA GCT CAT CAC GCA GCT CAT GCC CTT CGG CTG CCT CCT GGA CTA |
| E20M60 | Exon 20, 60-mer oligonucleotides represents Mut sequences, biotin labeled | 60 | Bio-CCT CAC CTC CAC CGT GCA GCT CAT CAT GCA GCT CAT GCC CTT CGG CTG CCT CCT GGA CTA |
| E21W60 | Exon 21, 60-mer oligonucleotides represents WT sequences, biotin labeled | 60 | Bio-CAA GAT CAC AGA TTT TGG GCT GGC CAA ACT GCT GGG TGC GGA AGA GAA AGA ATA CCA TGC |
| E21M60 | Exon 21, 60-mer oligonucleotides represents Mut sequences, biotin labeled | 60 | Bio-CAA GAT CAC AGA TTT TGG GCG GGC CAA ACA GCT GGG TGC GGA AGA GAA AGA ATA CCA TGC |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).